Dr. Khair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Expedition Trl
Suite 101
Gettysburg, PA 17325Phone+1 717-334-4033Fax+1 717-334-5599
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Hematology and Medical Oncology, 2009 - 2012- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2005 - 2009
NYIT College Of Osteopathic MedicineClass of 2005
Certifications & Licensure
MD State License 2012 - 2026
PA State License 2012 - 2026
NY State License 2008 - 2013
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 4 citationsPhase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).Walid L Shaib, Rupji Manali, Yuan Liu, Bassel El-Rayes, Patrick Loehrer
European Journal of Cancer. 2023-08-01 - 14 citationsRandomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.Cara Cacioppo, Brian L. Egleston, Dominique Fetzer, Colleen Burke Sands, Syeda A. Raza
Cancer Medicine. 2021-06-08
Press Mentions
- Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid TumorsMarch 24th, 2021
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
